RCKT: Rocket Pharmaceuticals Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | New 13G stake | Vanguard Portfolio Management | 5.35% | SEC |
Institutional ownership (Q2 2026)
180 institutions reported holding $340.35M of Rocket Pharmaceuticals Inc on Form 13F (198 the quarter before). 17 opened a new position and 34 sold out. Shares held by institutions: +3%.
| Largest holders | Shares | Value |
|---|---|---|
| RTW INVESTMENTS, LP | 17,687,772 | $60.49M |
| BlackRock, Inc. | 9,923,962 | $33.94M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,810,033 | $19.87M |
| CITIGROUP INC | 4,865,551 | $16.64M |
| MARSHALL WACE, LLP | 4,029,262 | $13.78M |
| MILLENNIUM MANAGEMENT LLC | 4,000,344 | $13.68M |
| Newtyn Management, LLC | 4,000,000 | $13.68M |
| MAVERICK CAPITAL LTD | 3,923,963 | $13.42M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,784,387 | $12.94M |
| AQR CAPITAL MANAGEMENT LLC | 3,386,162 | $11.58M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.